GRObio is actively pursuing a range of partnering opportunities to expand our platform and to access novel application spaces, including collaborations that will:
- Accelerate the expansion and development of GRObio’s current pipeline of programs
- Extend ProGly™ and other NSAA chemistries into new disease areas and therapeutic modalities
- Broaden the universe of NSAA chemistries and applications of our GRO platform
For more information, please contact our Business Development team at busdev@grobio.com
